1. Home
  2. SPCB vs GDTC Comparison

SPCB vs GDTC Comparison

Compare SPCB & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • GDTC
  • Stock Information
  • Founded
  • SPCB 1988
  • GDTC 2018
  • Country
  • SPCB Israel
  • GDTC Singapore
  • Employees
  • SPCB N/A
  • GDTC N/A
  • Industry
  • SPCB Semiconductors
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • GDTC Health Care
  • Exchange
  • SPCB Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • SPCB 31.4M
  • GDTC 29.4M
  • IPO Year
  • SPCB N/A
  • GDTC 2023
  • Fundamental
  • Price
  • SPCB $9.70
  • GDTC $2.89
  • Analyst Decision
  • SPCB Strong Buy
  • GDTC Buy
  • Analyst Count
  • SPCB 1
  • GDTC 1
  • Target Price
  • SPCB $18.00
  • GDTC $5.00
  • AVG Volume (30 Days)
  • SPCB 817.0K
  • GDTC 56.5K
  • Earning Date
  • SPCB 11-14-2024
  • GDTC 01-01-0001
  • Dividend Yield
  • SPCB N/A
  • GDTC N/A
  • EPS Growth
  • SPCB N/A
  • GDTC N/A
  • EPS
  • SPCB 1.02
  • GDTC N/A
  • Revenue
  • SPCB $26,843,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • SPCB $6.72
  • GDTC $14.71
  • Revenue Next Year
  • SPCB $16.91
  • GDTC N/A
  • P/E Ratio
  • SPCB $10.64
  • GDTC N/A
  • Revenue Growth
  • SPCB 5.23
  • GDTC N/A
  • 52 Week Low
  • SPCB $2.55
  • GDTC $1.20
  • 52 Week High
  • SPCB $18.95
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 48.22
  • GDTC 58.11
  • Support Level
  • SPCB $10.35
  • GDTC $2.35
  • Resistance Level
  • SPCB $11.43
  • GDTC $2.94
  • Average True Range (ATR)
  • SPCB 1.77
  • GDTC 0.27
  • MACD
  • SPCB -0.58
  • GDTC 0.05
  • Stochastic Oscillator
  • SPCB 4.98
  • GDTC 93.15

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: